Maxx's Top Stock for February 2022 - 7investing 7investing
Stock Tips Mobile Menu Dropdown Icon

Maxx’s Top Stock for February 2022

7investing Lead Advisor Maxx Chatsko's top stock to buy in February 2022 has what might be the best technology stack and most methodical approach in molecular testing. That makes it well positioned to emerge as a major winner.

February 1, 2022

Advisor: Maxx Chatsko

As investors are quickly finding out, companies cannot pay their employees in innovation. You cannot pay your rent or mortgage in innovation, either. Despite all of the hype and momentum in molecular testing, very few companies are well-positioned to emerge as significant winners within the competitive landscape. It’s going to be an absolute slugfest in the coming years.

7investing Lead Advisor Maxx Chatsko’s February 2022 recommendation has taken a methodical approach to building out what might be the best technology stack in molecular testing. Importantly, it has the one thing most competitors are desperate to achieve: scale. Although some peers may struggle to win over Wall Street in the coming years, this company should emerge as the most attractive investment opportunity.


The best technology stack in molecular testing. Period.

Hey everyone, I’m 7investing Lead Advisor Maxx Chatsko. I cover biotechnology and renewable energy here at 7investing, where we empower you to invest in your future by giving you our seven best stock market opportunities each and every month, each backed by the domain competence of one of our lead advisors.

Investor interest in molecular testing is certainly being tested right now as we’re in a steep correction. However, there are still asymmetrical opportunities for investors with a long-term mindset.

My recommendation for February 2022 is well positioned to become a major winner in molecular testing. The stock has sold off in recent months, but I don’t think it was deserved. I think it fell in sympathy with some of its peers, who, to be honest, some of which did deserve to sell off a little bit. But de-risking events in 2022 and beyond and revenue growth projections for the next few years suggest this will be among the first in the competitive landscape to win back the hearts and minds of Wall Street and recover some of its lost ground.

If you want to read my full research report, then you know what to do — go to And remember, it’s never too early or too late to start investing in your future.